NPCE icon

Neuropace
NPCE

Overview Fund Activity

24 hedge funds and large institutions have $25.9M invested in Neuropace in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 4 closing their positions.

Holders
24
Holders Change
-4
Holders Change %
-14.29%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
1
Increased
9
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$1.03M
2
Morgan Stanley
2
Morgan Stanley
New York
$3.26M
3
SCM
3
Soleus Capital Management
Connecticut
$3.53M
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$35.3K
5
Bank of America
5
Bank of America
North Carolina
$19.4K

Top Sellers

1
BG
1
Bellevue Group
Switzerland
$0
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$0
3
American Century Companies
3
American Century Companies
Missouri
$108K
4
OM
4
Opaleye Management
Massachusetts
$0
5
E
5
Ergoteles
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
E
26
Ergoteles
New York
– – -31,027 Closed
Barclays
27
Barclays
United Kingdom
$0 118 -3,100 -96%
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$0 58 -171 -75%
CFGS
29
Concourse Financial Group Securities
Alabama
– – – –
1
2